Variation in reported SARS-CoV-2 cases after testing policy changes
Lancet Infect Dis
.
2022 Oct;22(10):1418-1419.
doi: 10.1016/S1473-3099(22)00572-2.
Epub 2022 Aug 23.
Authors
Florence Halford
1
,
Sophie Nash
2
,
Elise Tessier
2
,
Meaghan Kall
2
,
Gavin Dabrera
2
Affiliations
1
COVID-19 Vaccines and Epidemiology Division, UK Health Security Agency, London NW9 5EQ, UK. Electronic address: feedback.c19epi@ukhsa.gov.uk.
2
COVID-19 Vaccines and Epidemiology Division, UK Health Security Agency, London NW9 5EQ, UK.
PMID:
36027903
PMCID:
PMC9398209
DOI:
10.1016/S1473-3099(22)00572-2
No abstract available
Publication types
Case Reports
Letter
MeSH terms
COVID-19 Testing
COVID-19*
Clinical Laboratory Techniques
Humans
Policy
SARS-CoV-2*